Signature reversion of three disease-associated gene signatures prioritizes cancer drug repurposing candidates https://www.biorxiv.org/content/10.1101/2023.03.10.532074v1?med=mas
Signature reversion of three disease-associated gene signatures prioritizes cancer drug repurposing candidates https://www.biorxiv.org/content/10.1101/2023.03.10.532074v1?med=mas